bridge7 exists to meet the global need for world class cancer care by providing on-demand consultation and expert insights.

 

Our bridge7 Team

 
meir-slate.jpg

meir dick

CEO

A serial entrepreneur, Meir served as executive at previous executive roles in VISR and ScienceScape and is passionate about AI and improving healthcare.

bob-slate.jpg

robert fenwick

Business Development

Robert is a health care software and medical device leader with 30+ years of product innovation market development for global growth and customer delight in start up, turnaround, and large corporate venues.

chris-slate.jpg

chris mcintosh

CML

Chris is a researcher at the Princess Margaret Cancer Centre and has developed AI tools in radiotherapy, including commercially available automated treatment planning software. Chris' goal is to use automation to provide new insights in cancer care and to improve standardization and treatment access.

tom-slate.jpg

tom purdie

CCO

An Associate Professor in the Department of Radiation Oncology at the University of Toronto, Tom has been a medical physicist for over 15 years. He has previously commercialized two automated radiotherapy planning software products. Tom is motivated by improving accessibility to shared expertise and high quality care. 

 

Our bridge7 Values

 
bridge7 Values.png